Morgan Stanley Smith Barney LLC submitted a Form 144 notice proposing the resale of common shares. The filing lists multiple grant/vesting events tied to Performance Stock Units and restricted stock vesting with specific share counts and dates.
The entry includes share line items of 4,778 (08/23/2025), 840 (08/23/2025), 4,274 (08/24/2025) and 4,829 (11/10/2024). The header shows 14721, an NYSE listing and the date 05/08/2026.
Covista Inc. reported third-quarter 2026 results with revenue of $487.0 million, higher than the prior-year period. Income from continuing operations was $58.0 million, while a loss in discontinued operations reduced net income to $41.6 million.
For the first nine months of fiscal 2026, Covista generated revenue of $1.45 billion and net income of $179.8 million. Operating cash flow was strong at $346.5 million, supporting $238.2 million of share repurchases and significant debt refinancing activity.
The company replaced its remaining 5.50% Senior Secured Notes with a new $510.0 million Term Loan B maturing in 2033, and maintained compliance with all credit facility covenants. Deferred revenue rose, reflecting future educational services already billed to students.
Covista Inc. reported third quarter fiscal 2026 results showing steady growth and stronger guidance. Revenue for the quarter was $487.0 million, up 4.5% year over year, with operating income edging up to $91.3 million. Net income from continuing operations was $58.0 million, while a loss from discontinued operations reduced total net income to $41.6 million.
Total students surpassed 100,000, with enrollment up 6.8% year over year and growth in every segment. Chamberlain revenue rose 2.3% with slightly higher operating income, Walden revenue grew 4.6% but with lower operating income, and Medical and Veterinary revenue increased 8.9% with operating income up 18.7%.
For the full fiscal year 2026, Covista raised its revenue outlook to $1,930–$1,945 million, or about 8–9% growth, and lifted adjusted earnings per share guidance to $7.95–$8.15, or roughly 19–22% growth year over year. Adjusted EBITDA for the quarter was $127.9 million, and net leverage stood at 0.7x, supported by strong cash generation and reduced long-term debt.
Covista Inc reports a 13G filing showing FMR LLC beneficially owns 2,654,243.58 shares, or 7.7% of common stock, as of 03/31/2026. The filing lists sole dispositive power for 2,654,243.58 shares and identifies Abigail P. Johnson as having shared dispositive authority. The signature dates are 05/05/2026.
Covista Inc Schedule 13G: Vanguard Capital Management reports beneficial ownership of 1,751,336 shares of Common Stock, representing 5.07% of the class as of 03/31/2026. The filer reports sole dispositive power over 1,751,336 shares and sole voting power over 260,800 shares. The filing states the ownership reflects holdings across Vanguard Capital Management LLC and certain affiliates and includes shares held by managed funds and client accounts. The filing was signed on 04/29/2026.
Covista Inc reports that Vanguard Portfolio Management holds 2,451,249 shares of Common Stock, representing 7.1% of the class. The filing shows Vanguard has sole dispositive power over 2,451,249 shares and sole voting power over 29,643 shares. The disclosure identifies the reporting chain of Vanguard Portfolio Management LLC and affiliated voting/dispositive arrangements.
Covista Inc. executive Liles Scott, President, Medical and Vet, used company shares to cover taxes on vested equity. On April 15, 2026, 448 shares of Common Stock were withheld at $112.49 per share to satisfy tax obligations tied to previously awarded restricted stock units. After this non-market, tax-withholding disposition, Scott directly holds 13,103 shares of Covista common stock.